FATE THERAPEUTICS INC - 10-Q Filing
Fate Therapeutics filed a Form 10-Q for the quarter ended March 31, 2026. The filing includes financial data and disclosures related to fair value measurements of investments, including corporate debt securities, commercial paper, money market funds, U.S. Treasury securities, and foreign government debt securities.
Tickers: $FATE